effect overlay
activetrials

Pioneering solutions, saving lives

Research is critical to combatting brain disease and improving the lives of those impacted, today and in the future. 

Conducted by The Royal Melbourne Hospital’s Departments of Neurology and Neurosurgery, the active research programs and clinical trials supported by the Foundation cover an extensive breadth of neurological conditions.

Patients wishing to participate are encouraged to view the relevant trial and contact the trial co-ordinator for more information.

Brain Tumour / Neurosurgery:NsurgClerk@mh.org.au
Dementia:DementiaTrials@mh.org.au
Epilepsy:EpilepsyCoordinator@mh.org.au
Huntington’s Disease:RMHHuntingtonDiseaseStudies@mh.org.au
Movement Disorders:MovementDisorders@mh.org.au
Multiple Sclerosis:MSClinic@mh.org.au 
Neurophysiology:RMH-ClinicalNeurophysiology@mh.org.au
Stroke:RMH-StrokeResearchTeam@mh.org.au
General:Neuro.Foundation@mh.org.au
Stroke
Stroke
Coagulation in Vasculopathy and COVID-19

Coagulation in Vasculopathy and COVID-19

HREC: 2020.191
Principal Investigator: Prof Bruce Campbell
Coordinator contact:
Funding: Non-Commercial
Multiple sclerosis
Multiple Sclerosis
Changes in Cerebrospinal Fluid (CSF) in MS

Changes in Cerebrospinal Fluid (CSF) in MS

HREC: 2020.017
Principal Investigator: Dr Mastura Monif
Coordinator contact:
Funding: Non-Commercial
Epilepsy
Epilepsy
Drug Resistant Epilepsy

Drug Resistant Epilepsy

HREC: 2019.321
Principal Investigator: Prof Patrick Kwan
Coordinator contact:
Funding: Non-Commercial
Multiple sclerosis
Multiple Sclerosis
Early detection of neurodegeneration in MS

Early detection of neurodegeneration in MS

HREC: 2019.132
Principal Investigator: Prof Trevor Kilpatrick
Coordinator contact: Prof Tomas Kalincik
Funding: Non-Commercial
Stroke
Stroke
Cognitive outcomes after cerebral ischaemia

Cognitive outcomes after cerebral ischaemia

HREC: 2017.148
Principal Investigator: A/Prof Nawaf Yassi
Coordinator contact:
Funding: Non-Commercial